Navigation Links
Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
Date:1/12/2009

PALO ALTO, Calif., Jan. 12 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it has achieved its first candidate selection milestone payment of $3 million from its collaboration partner, GlaxoSmithKline. Anacor may receive future milestone payments and royalties should this product candidate progress to clinical development and commercial sales.

"We are pleased with the scientific progress we have made as a result of the alliance we have built between our team and GSK. The strength of this collaboration is reflected in our ability to move our first compound into preclinical development only 15 months since starting our work together," said Jacob J. Plattner, Ph.D., Senior Vice President of Research at Anacor Pharmaceuticals. "We believe that our boron-based platform will continue to allow the collaboration team to successfully identify additional novel product candidates."

In October 2007, Anacor and GlaxoSmithKline announced a worldwide strategic alliance for the discovery, development and commercialization of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor's proprietary boron-based chemistry for use against selected antiviral and antibacterial targets.

In December 2008, Anacor closed a $50 million preferred stock financing with participation from GlaxoSmithKline, Schering Corporation and existing investors, including Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures. Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform. The combined ownership of GlaxoSmithKline and Schering Corporation is less than 20 percent of Anacor's outstanding shares.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platfor
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anacor Files Registration Statement for Initial Public Offering
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
4. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
5. Anacor Raises $50 Million in Equity Financing
6. Pharsight Achieves First License Sale for Public-Source Database
7. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
8. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
9. Signalife Achieves $1.98 Million Sales Orders Thus Far
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Erlab , the ... since 1968 and Burdinola, supplier of laboratory furniture solutions, ... filtered fume hood. , By integrating ... Burdinola will now offer an innovative solution utilizing the ... of chemicals, best-in-class detection technology, and communication for security ...
(Date:9/23/2014)... 23, 2014 For the fifth time since ... list of the fastest-growing companies. , “We’re so proud ... again by Inc. Magazine,” ExakTime CEO Tony Pappas said. , ... posting a three-year growth rate of 61 percent from 2010 ... by more than 40 percent. , Pappas cited strong performance ...
(Date:9/23/2014)... 23, 2014  Age Defying Dermatology ® , owned ... become one of the first clinics in the Bay ... laser for tattoo removal. The treatment safely and effectively ... years, tattoo removal has been a lengthy, painful, and ... is an opportunity to erase tattoo pigment more efficiently ...
(Date:9/23/2014)... Cambridge Semantics, the leading provider of Smart Data ... the recent ‘Hype Cycle for Life Sciences 2014 ’ ... key insights pertaining to the benefits in the knowledge ... Shanler and Stephen Davies, “The use of these systems ... scientific stakeholders, and support collaboration and innovation strategies as ...
Breaking Biology Technology:Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ExakTime Makes Inc. 5000 List for the Fifth Time 2Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2
... Aug. 20 Vical Incorporated,(Nasdaq: VICL ) ... with,the appointment of Andrew R. de Guttadauro as ... Mr. de Guttadauro was Senior Director of,Strategy at ... overseeing the commercial development of that company,s Zevalin,the ...
... with Sales Team Forming and Increased Space, Poised for ... Medical Technologies,Inc., which is developing innovative devices for the ... a VP of Sales, Joseph W.,Rafferty, and has started ... its first product, Pathway PV(TM) Atherectomy System. Recently ...
... and CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... the second quarter of 2007 increased more than,35% over ... 139 times,revenues of just $13,351 for the same period ... half of 2007 were $3,256,000 compared to only,$24,374 in ...
Cached Biology Technology:Vical Names Andrew de Guttadauro Vice President, Corporate Development 2Vical Names Andrew de Guttadauro Vice President, Corporate Development 3Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6
(Date:9/22/2014)... ATLANTA September 23, 2014 A new American ... Supplemental Nutrition Assistance Program (SNAP), previously known as ... scores compared with income eligible non-participants. The authors ... programs aimed at enhancing the dietary quality of ... assist low-income individuals and households with the resources ...
(Date:9/22/2014)... Yale University researchers are studying a potential new ... respiratory disease in which scars develop in the lungs ... microRNA mimic, miR-29, which is delivered to lung tissue ... fibrosis, it reversed fibrosis after several days. , ... EMBO Molecular Medicine . , "The mimic, when ...
(Date:9/22/2014)... sequencing technologies continue to evolve rapidly, becoming part of ... appropriate policies and regulatory frameworks to address potential challenges, ... issue of the Journal of Law, Medicine & ... with the Center for Medical Ethics and Health Policy ... tools to jumpstart this process. , Experts with ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... an Israeli start-up company, launched its first "solar farm" near ... systems developed by Prof. David Faiman of Ben-Gurion University ... Faiman, who is chairman of the Department of ... for Desert Research, believes the new system will harvest more ...
... for the 61st Annual Meeting of the Rocky Mountain ... 11-13 May 2009 in Orem, Utah. Utah Valley ... library building on the UVU campus. Brigham Young University ... and industry scientists, and graduate and undergraduate students, will ...
... Ill. Researchers at the University of Illinois have ... one or more molecules into the cytoplasm or the ... amounts of cargo, the nanoneedle can also be used ... "Nanoneedle-based delivery is a powerful new tool for studying ...
Cached Biology News:Ben-Gurion University research and technology used in new solar energy farm 2Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2
...
... The Bio-Plex maintenance, calibration, ... is a custom 96-well plate ... validation, and calibration procedures using ... This MCV plate is for ...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... real-time PCR detection system holds 48 x 0.2 ... of 48 LEDs independently excites fluorescence (470-500 nm) ... photodiodes detects emitted light (523-543 nm and 540-700 ... Mini cycler, whose Peltier heat pumps provide superb ...
Biology Products: